GLP-1 medications like Ozempic, Wegovy, and Mounjaro are transforming obesity and diabetes treatment — but are they also affecting oral health?
In this episode, we examine the emerging research surrounding semaglutide and its potential connection to dry mouth, bad breath, enamel erosion, reflux-related dental damage, and gum inflammation. We explore what current studies have documented, the proposed biological mechanisms involving salivary glands and GLP-1 receptors, and why saliva plays such a critical role in protecting the mouth.
This conversation is not anti-medication. Instead, it focuses on prevention, awareness, and practical strategies patients can use to better protect their oral health while benefiting from these therapies.
Topics include:
Xerostomia and salivary dysfunction
Acid reflux and enamel erosion
Oral microbiome disruption
Saliva’s role in remineralization
GLP-1 receptor biology
Evidence vs speculation in current research
Preventive oral care strategies for GLP-1 users
A science-based discussion designed to help patients make informed decisions and protect long-term dental health.